Ivenix Infusion System (IIS), Large Volume Pump (LVP) Software: 5.0.0 and 5.0.1 Part Number: LVP...

FDA Device Recall #Z-2635-2023 — Class II — April 22, 2022

Recall Summary

Recall Number Z-2635-2023
Classification Class II — Moderate risk
Date Initiated April 22, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Kabi USA, LLC
Location North Andover, MA
Product Type Devices
Quantity 1344 pumps

Product Description

Ivenix Infusion System (IIS), Large Volume Pump (LVP) Software: 5.0.0 and 5.0.1 Part Number: LVP-SW-0004. Indicated for use in a hospital and in outpatient care environments for the controlled administration of fluids through clinically accepted routes of administration.

Reason for Recall

Start-up time for the flow rate range greater than 50 ml/hr, and less than 200 ml/hr may exceed the specified 6 minutes, depending on the characteristics of air bubble entrapment within the Intermediate Pumping Chamber (IPC) of the administration set

Distribution Pattern

US Nationwide distribution in the states of NJ, WI.

Lot / Code Information

(UDI): 00811505030122 Software Version: 5.0.0 and 5.0.1

Other Recalls from Fresenius Kabi USA, LLC

Recall # Classification Product Date
Z-1048-2026 Class II Ivenix Infusion System (IIS), LVP Software: LVP... Nov 21, 2025
Z-0885-2026 Class I Ivenix Infusion System (IIS), LVP Software LVP-... Nov 14, 2025
Z-0848-2026 Class II Ivenix Infusion System (IIS), Large Volume Pump... Nov 3, 2025
Z-0586-2026 Class I IVENIX INFUSION SYSTEM, LVP Primary Administrat... Nov 3, 2025
Z-0378-2026 Class II Ivenix Infusion System (IIS), Large Volume Pump... Sep 3, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.